Growth Differentiation Factor-15 Is Not Modified by Sacubitril/Valsartan and Is an Independent Marker of Risk in Patients With Heart Failure and Reduced Ejection Fraction: The PARADIGM-HF Trial
European Journal of Heart Failure - United States
doi 10.1002/ejhf.1301
Full Text
Open PDFAbstract
Available in full text
Date
September 11, 2018
Authors
Publisher
Wiley